Stentys, S.A.S. announced today that its CEO, Gonzague Issenmann, will present at Medtech Insight and Windhover Information’s ‘In3 Europe’ investor conference, Sept. 18-20, 2006, at the Crowne Plaza City Center, Brussels, Belgium. Stentys has developed a patented product to treat certain cardiac artery diseases so that hundreds of thousands of patients might avoid open-chest surgery.